Tango Therapeutics, Inc. (TNGX) P/E Ratio History
Historical price-to-earnings valuation from 2026 to 2026
Loading P/E history...
TNGX Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Tango Therapeutics, Inc. (TNGX) trades at a price-to-earnings ratio of -27.0x, with a stock price of $23.48 and trailing twelve-month earnings per share of $-0.87.
Compared to the Healthcare sector median P/E of 22.3x, TNGX trades at a 221% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, TNGX trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our TNGX DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
TNGX P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 7.3Lowest | - | +5167%Best | |
| $283B | 27.9 | 1.28 | +191% | |
| $277B | 15.4 | 0.73Best | +8% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
See TNGX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TNGX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TNGX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTNGX — Frequently Asked Questions
Quick answers to the most common questions about buying TNGX stock.
Is TNGX stock overvalued or undervalued?
TNGX current P/E: -27.0x. 5-year average P/E: N/A. Percentile: N/A.
How does TNGX's valuation compare to peers?
Tango Therapeutics, Inc. P/E of -27.0x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is TNGX's PEG ratio?
TNGX PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2026-2026.